
									Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2023 | 0 | 9.951.078 | 462.750 | 1 | ||
| 2021 | 0 | 9.999.064 | 330.250 | 1 | ||
| 2020 | 0 | 9.800.000 | 53.896 | 1 | ||
							Total number of partners: 96
							Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 96
Frequent / Rare Partner Ratio: 0
						
| Start date | Project | acronym | role | funding | partners | 
|---|---|---|---|---|---|
| 2023-01-01 | Elucidation of risk factors and health determinants associated with PROGRESSION of Monoclonal Gammopathies to Multiple Myeloma | ELMUMY | participant | 9.951.078 | 14 | 
| 2021-01-01 | Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases | GenoMed4ALL | participant | 9.999.064 | 28 | 
| 2020-02-01 | Connect and align ELIXIR Nodes to deliver sustainable FAIR life-science data management services | ELIXIR-CONVERGE | participant | 9.800.000 | 57 |